Fuji Pharma Co.,Ltd.JP:4554Income statement

Market cap
¥57.8B
P/E ratio
25.4x
2011/092012/092013/092014/092015/092016/092017/092018/092019/092020/092021/092022/092023/092024/092025/09
Revenue21,62321,52025,17429,21531,68034,22935,38737,90936,27933,79333,99035,42640,88946,13851,677
Revenue growth (%)-
Cost of revenue---16,83518,70920,69120,67121,95920,48318,92119,23920,86724,37428,29430,914
Gross profit---12,37912,97013,53714,71515,95015,79614,87214,75114,55816,51417,84420,763
Gross margin (%)---
Operating margin (%)---
Operating expenses ---9,2069,7189,96910,40111,55911,62211,73211,40210,78112,65613,96315,773
Operating income ---3,1733,2513,5684,3144,3914,1733,1393,3493,7773,8583,8804,990
Income before tax 3,5452,6983,3763,1983,0993,2514,6284,4724,1692,9833,2503,7254,5194,4454,459
Pretax margin (%)16.412.513.410.99.89.513.111.811.58.89.610.511.19.68.6
Provision for income taxes---1,1531,0121,0291,2281,0999988329381,0269632,1281,000
Effective tax rate (%)---
Net income 2,2041,3702,0682,0782,0922,1183,3013,3722,9622,0852,4322,6973,4356,1473,000
Net income margin (%)
Earnings per share167.6397.09146.48140.53137.55141.64220.63112.6897.0466.9490.54111.01141.37252.85122.94
Dividend per share--------292929353742.545.5
EBITDA---
EBITDA margin (%)---